BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 12117721)

  • 1. NO attenuates insulin signaling and motility in aortic smooth muscle cells via protein tyrosine phosphatase 1B-mediated mechanism.
    Sreejayan N; Lin Y; Hassid A
    Arterioscler Thromb Vasc Biol; 2002 Jul; 22(7):1086-92. PubMed ID: 12117721
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nitric oxide-induced inhibition of aortic smooth muscle cell motility: role of PTP-PEST and adaptor proteins p130cas and Crk.
    Lin Y; Ceacareanu AC; Hassid A
    Am J Physiol Heart Circ Physiol; 2003 Aug; 285(2):H710-21. PubMed ID: 12714323
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nitric oxide-induced motility in aortic smooth muscle cells: role of protein tyrosine phosphatase SHP-2 and GTP-binding protein Rho.
    Chang Y; Ceacareanu B; Dixit M; Sreejayan N; Hassid A
    Circ Res; 2002 Sep; 91(5):390-7. PubMed ID: 12215487
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic insulin treatment amplifies PDGF-induced motility in differentiated aortic smooth muscle cells by suppressing the expression and function of PTP1B.
    Zhuang D; Pu Q; Ceacareanu B; Chang Y; Dixit M; Hassid A
    Am J Physiol Heart Circ Physiol; 2008 Jul; 295(1):H163-73. PubMed ID: 18456732
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment with insulin uncovers the motogenic capacity of nitric oxide in aortic smooth muscle cells: dependence on Gab1 and Gab1-SHP2 association.
    Dixit M; Zhuang D; Ceacareanu B; Hassid A
    Circ Res; 2003 Nov; 93(10):e113-23. PubMed ID: 14551245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NO alters cell shape and motility in aortic smooth muscle cells via protein tyrosine phosphatase 1B activation.
    Hassid A; Yao J; Huang S
    Am J Physiol; 1999 Sep; 277(3):H1014-26. PubMed ID: 10484424
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Counter-regulatory function of protein tyrosine phosphatase 1B in platelet-derived growth factor- or fibroblast growth factor-induced motility and proliferation of cultured smooth muscle cells and in neointima formation.
    Chang Y; Ceacareanu B; Zhuang D; Zhang C; Pu Q; Ceacareanu AC; Hassid A
    Arterioscler Thromb Vasc Biol; 2006 Mar; 26(3):501-7. PubMed ID: 16373608
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms related to NO-induced motility in differentiated rat aortic smooth muscle cells.
    Pu Q; Zhuang D; Thakran S; Hassid A
    Am J Physiol Heart Circ Physiol; 2011 Jan; 300(1):H101-8. PubMed ID: 21037226
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Essential role of protein kinase G and decreased cytoplasmic Ca2+ levels in NO-induced inhibition of rat aortic smooth muscle cell motility.
    Zhuang D; Ceacareanu AC; Ceacareanu B; Hassid A
    Am J Physiol Heart Circ Physiol; 2005 Apr; 288(4):H1859-66. PubMed ID: 15576431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nitric oxide attenuates insulin- or IGF-I-stimulated aortic smooth muscle cell motility by decreasing H2O2 levels: essential role of cGMP.
    Zhuang D; Ceacareanu AC; Lin Y; Ceacareanu B; Dixit M; Chapman KE; Waters CM; Rao GN; Hassid A
    Am J Physiol Heart Circ Physiol; 2004 Jun; 286(6):H2103-12. PubMed ID: 14751855
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Requirement of protein tyrosine phosphatase SHP2 for NO-stimulated vascular smooth muscle cell motility.
    Brown C; Lin Y; Hassid A
    Am J Physiol Heart Circ Physiol; 2001 Oct; 281(4):H1598-605. PubMed ID: 11557549
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Calcium-dependent epidermal growth factor receptor transactivation mediates the angiotensin II-induced mitogen-activated protein kinase activation in vascular smooth muscle cells.
    Eguchi S; Numaguchi K; Iwasaki H; Matsumoto T; Yamakawa T; Utsunomiya H; Motley ED; Kawakatsu H; Owada KM; Hirata Y; Marumo F; Inagami T
    J Biol Chem; 1998 Apr; 273(15):8890-6. PubMed ID: 9535870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dual role of SRC homology domain 2-containing inositol phosphatase 2 in the regulation of platelet-derived growth factor and insulin-like growth factor I signaling in rat vascular smooth muscle cells.
    Sasaoka T; Kikuchi K; Wada T; Sato A; Hori H; Murakami S; Fukui K; Ishihara H; Aota R; Kimura I; Kobayashi M
    Endocrinology; 2003 Sep; 144(9):4204-14. PubMed ID: 12933696
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppression of PKG by PDGF or nitric oxide in differentiated aortic smooth muscle cells: obligatory role of protein tyrosine phosphatase 1B.
    Zhuang D; Balani P; Pu Q; Thakran S; Hassid A
    Am J Physiol Heart Circ Physiol; 2011 Jan; 300(1):H57-63. PubMed ID: 21057040
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduction of protein tyrosine phosphatase 1B increases insulin-dependent signaling in ob/ob mice.
    Gum RJ; Gaede LL; Koterski SL; Heindel M; Clampit JE; Zinker BA; Trevillyan JM; Ulrich RG; Jirousek MR; Rondinone CM
    Diabetes; 2003 Jan; 52(1):21-8. PubMed ID: 12502489
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NO increases protein tyrosine phosphatase activity in smooth muscle cells: relationship to antimitogenesis.
    Dhaunsi GS; Matthews C; Kaur K; Hassid A
    Am J Physiol; 1997 Mar; 272(3 Pt 2):H1342-9. PubMed ID: 9087610
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inducible nitric oxide synthase (iNOS) expression upregulates p21 and inhibits vascular smooth muscle cell proliferation through p42/44 mitogen-activated protein kinase activation and independent of p53 and cyclic guanosine monophosphate.
    Kibbe MR; Li J; Nie S; Watkins SC; Lizonova A; Kovesdi I; Simmons RL; Billiar TR; Tzeng E
    J Vasc Surg; 2000 Jun; 31(6):1214-28. PubMed ID: 10842159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanism for differential effect of protein-tyrosine phosphatase 1B on Akt versus mitogen-activated protein kinase in 3T3-L1 adipocytes.
    Shimizu S; Maegawa H; Egawa K; Shi K; Bryer-Ash M; Kashiwagi A
    Endocrinology; 2002 Dec; 143(12):4563-9. PubMed ID: 12446583
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of SHP-1, Kv.1.2, and cGMP in nitric oxide-induced ERK1/2 MAP kinase dephosphorylation in rat vascular smooth muscle cells.
    Palen DI; Belmadani S; Lucchesi PA; Matrougui K
    Cardiovasc Res; 2005 Nov; 68(2):268-77. PubMed ID: 15967421
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduction of protein-tyrosine phosphatase-1B increases insulin signaling in FAO hepatoma cells.
    Clampit JE; Meuth JL; Smith HT; Reilly RM; Jirousek MR; Trevillyan JM; Rondinone CM
    Biochem Biophys Res Commun; 2003 Jan; 300(2):261-7. PubMed ID: 12504077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.